Carregant...
A dose–schedule finding design for phase I–II clinical trials
Dose-finding methods aiming at identifying an optimal dose of a treatment with a given schedule may be at a risk of misidentifying the best treatment for patients. In this article we propose a phase I/II clinical trial design to find the optimal dose-schedule combination. We define schedule as the m...
Guardat en:
| Publicat a: | J R Stat Soc Ser C Appl Stat |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4747255/ https://ncbi.nlm.nih.gov/pubmed/26877554 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/rssc.12113 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|